MultiversX vs Injective — how do they compare? MultiversX trades at Rp56,064 (market cap Rp1,69T, Rp146,57M 24h volume), while Injective trades at Rp86,066 (market cap Rp8,58T, Rp1,25T 24h volume). The key difference: Injective is far larger — about 5.1× MultiversX's market cap, and MultiversX's circulating supply is 30,3M EGLD versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold MultiversX for 82 Days and Injective for 36 Days on average.
| EGLD | INJ | |
|---|---|---|
Market Cap | Rp1,69T | Rp8,58T |
Volume (24h) | Rp146,57M | Rp1,25T |
Circulating Supply | 30,3M EGLD | 100M INJ |
Typical Hold Time | 82 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
MultiversX (EGLD) is trading at Rp56,064 with a market cap of Rp1.69 trillion, showing bullish technical signals across moving averages and oscillators. The current price sits above key resistance at Rp54,427, with next resistance at Rp56,541. RSI levels indicate potential overbought conditions at 73.26 on the 6-day timeframe. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautiously bullish with strong technical momentum, though overbought RSI suggests potential near-term consolidation. Key opportunities include continued technical strength and network adoption growth. Major risks include high volatility, regulatory uncertainty in crypto markets, and potential profit-taking pressure given elevated RSI levels.
Injective (INJ) is trading at Rp86,314 with a market cap of Rp8.6T, showing bullish technical signals from moving averages while oscillators remain neutral. The token is currently positioned between key support at Rp86,075 and resistance at Rp89,928, with an average hold time of 36 days indicating moderate investor patience. Recent technical momentum suggests potential upward movement if it can break through the immediate resistance level.
Overall outlook remains cautiously optimistic with technical strength supporting potential gains, though the neutral oscillator readings suggest consolidation may precede further movement. Key opportunities include the bullish moving average alignment and strong support levels, while risks involve typical crypto volatility and the need for sustained volume to confirm the bullish trend.
What Pluang investors did over the last 30 days
Latest headlines on both assets
MultiversX (EGLD) is a blockchain protocol that seeks to offer extremely fast transaction speeds by using sharding. The project is known as a technology ecosystem for the new internet, which includes fintech, decentralized finance and the Internet of Things. The native token, EGLD, is used for paying network fees, staking and rewarding validators
Read more on EGLD →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →